
Tolerance Bio
Tolerance Bio will increase health span by preserving and restoring the function of the thymus, the master regulator of immune tolerance.
$17.2M Seed ·
Source: fundraisingfox.com
Funding history ↓Signals
About Tolerance Bio
Immune-mediated diseases represent a significant unmet medical challenge: cancer, autoimmunity, transplant rejection, infections, immune deficiencies, and allergi
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Seed | $17.2M | — | fundraisingfox.com |
Timeline
- Website created
Companies like Tolerance Bio
TTinkeso TherapeuticsKKhartis Therapeutics$95M Series B+ · Aug 2026
BBionyra$165M Series A · Jun 2026
MMirador Therapeutics$250M Series B+ · Jan 2026
OOuro Medicines$120M Series A · Jan 2025
CCitryll$92.5M Series B+ · Dec 2024
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/tolerance-bio (get a free API key).